171 related articles for article (PubMed ID: 31687197)
1. Identification of Underlying Inflammation in Vogt-Koyanagi-Harada Disease with Sunset Glow Fundus by Multiple Analyses.
Murata T; Sako N; Takayama K; Harimoto K; Kanda K; Herbort CP; Takeuchi M
J Ophthalmol; 2019; 2019():3853794. PubMed ID: 31687197
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A multicenter study.
Takeuchi M; Nakai S; Usui Y; Namba K; Suzuki K; Harada Y; Kusuhara S; Kaburaki T; Tanaka R; Takeuchi M; Mizuki N; Nakai K; Goto H; Herbort CP
Saudi J Ophthalmol; 2022; 36(4):380-386. PubMed ID: 36618573
[TBL] [Abstract][Full Text] [Related]
3. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
Jap A; Chee SP
Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
[TBL] [Abstract][Full Text] [Related]
4. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis.
Fabro F; Herbort CP
Klin Monbl Augenheilkd; 2018 Apr; 235(4):424-435. PubMed ID: 29669371
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
6. Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: a pilot report.
Balci O; Gasc A; Jeannin B; Herbort CP
Int Ophthalmol; 2017 Jun; 37(3):737-748. PubMed ID: 27486023
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine green angiography guided management of vogt-koyanagi-harada disease.
Bouchenaki N; Herbort CP
J Ophthalmic Vis Res; 2011 Oct; 6(4):241-8. PubMed ID: 22454746
[TBL] [Abstract][Full Text] [Related]
8. Choroidal bulging in patients with Vogt-Koyanagi-Harada disease in the non-acute uveitic stage.
Sakata VM; da Silva FT; Hirata CE; Takahashi WY; Costa RA; Yamamoto JH
J Ophthalmic Inflamm Infect; 2014 Feb; 4(1):6. PubMed ID: 24548697
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt-Koyanagi-Harada disease.
Tobaigy MF; Abouammoh MA; AlBloushi AF; Saifaldein AA; Gikandi P; Almousa AN; Herbort CP; El-Asrar AA
Acta Ophthalmol; 2023 Dec; ():. PubMed ID: 38131519
[TBL] [Abstract][Full Text] [Related]
10. Choroidal Vascularity Index in Vogt-Koyanagi-Harada Disease: An EDI-OCT Derived Tool for Monitoring Disease Progression.
Agrawal R; Li LK; Nakhate V; Khandelwal N; Mahendradas P
Transl Vis Sci Technol; 2016 Jul; 5(4):7. PubMed ID: 27525196
[TBL] [Abstract][Full Text] [Related]
11. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.
da Silva FT; Hirata CE; Sakata VM; Olivalves E; Preti R; Pimentel SL; Gomes A; Takahashi WY; Costa RA; Yamamoto JH
BMC Ophthalmol; 2012 Aug; 12():40. PubMed ID: 22889440
[TBL] [Abstract][Full Text] [Related]
12. Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease.
Miura M; Makita S; Yasuno Y; Tsukahara R; Usui Y; Rao NA; Ikuno Y; Uematsu S; Agawa T; Iwasaki T; Goto H
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4467-4476. PubMed ID: 28863408
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series.
Elahi S; Gillmann K; Gasc A; Jeannin B; Herbort CP
J Curr Ophthalmol; 2019 Jun; 31(2):180-187. PubMed ID: 31317097
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.
Knecht PB; Mantovani A; Herbort CP
Int Ophthalmol; 2013 Oct; 33(5):571-7. PubMed ID: 23277207
[TBL] [Abstract][Full Text] [Related]
15. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
Lee EK; Lee SY; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
[TBL] [Abstract][Full Text] [Related]
16. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
17. Predictive Biomarker for Progression Into the Sunset Glow Fundus of Vogt-Koyanagi-Harada Disease, Using Adaptive Binarization of Fundus Photographs.
Komuku Y; Ishikawa H; Ide A; Matsuoka T; Fukuyama H; Okadome T; Gomi F
Transl Vis Sci Technol; 2020 Oct; 9(11):10. PubMed ID: 33133773
[TBL] [Abstract][Full Text] [Related]
18. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.
Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
[TBL] [Abstract][Full Text] [Related]
20. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
